Your browser doesn't support javascript.
loading
Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection.
Wang, Shaohui; Ju, Xianghong; Heuler, Joshua; Zhang, Keshan; Duan, Zhibian; Warnakulasuriya Patabendige, Hiran Malinda Lamabadu; Zhao, Song; Sun, Xingmin.
Affiliation
  • Wang S; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Ju X; Department of Infectious Diseases and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, USA.
  • Heuler J; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Zhang K; Department of Infectious Diseases and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, USA.
  • Duan Z; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Warnakulasuriya Patabendige HML; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Zhao S; Department of Infectious Diseases and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts, USA.
  • Sun X; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
Infect Immun ; 91(4): e0016922, 2023 04 18.
Article in En | MEDLINE | ID: mdl-36939332
Bacterial flagella are involved in infection through their roles in host cell adhesion, cell invasion, auto-agglutination, colonization, the formation of biofilms, and the regulation and secretion of nonflagellar bacterial proteins that are involved in the virulence process. In this study, we constructed a fusion protein vaccine (FliCD) containing the Clostridioides difficile flagellar proteins FliC and FliD. The immunization of mice with FliCD induced potent IgG and IgA antibody responses against FliCD, protected mice against C. difficile infection (CDI), and decreased the C. difficile spore and toxin levels in the feces after infection. Additionally, the anti-FliCD serum inhibited the binding of C. difficile vegetative cells to HCT8 cells. These results suggest that FliCD may represent an effective vaccine candidate against CDI.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections Limits: Animals Language: En Journal: Infect Immun Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections Limits: Animals Language: En Journal: Infect Immun Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos